ly 303511 and tetraethylammonium

ly 303511 has been researched along with tetraethylammonium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, QM; Sheveleva, E; Sun, H; Xu, B	1

Other Studies

1 other study(ies) available for ly 303511 and tetraethylammonium

Article	Year
LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism. Toxicology and applied pharmacology, 2008, Oct-01, Volume: 232, Issue:1 Topics: Androstadienes; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Chromones; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Induction; Glucocorticoids; Morpholines; Myocytes, Cardiac; Nimodipine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channel Blockers; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Tetraethylammonium; Time Factors; Wortmannin	2008

Article

Year

LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism.

Toxicology and applied pharmacology, 2008, Oct-01, Volume: 232, Issue:1

Topics: Androstadienes; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Chromones; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Induction; Glucocorticoids; Morpholines; Myocytes, Cardiac; Nimodipine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channel Blockers; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Tetraethylammonium; Time Factors; Wortmannin

2008